GlycA is not a useful biomarker of inflammation in sickle cell disease.

Int J Lab Hematol · 2018 · PMC6419740 · PMID 30152174

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Patients with the clinically more severe SCA genotype were found to have decreased plasma GlycA levels compared with the less clinically severe HbSC genotype (321.4 ± 70.0 μmol/L vs 341.4 ± 70.0 μmol/L; P = 0.0905), but the results did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.